1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.
(
- Contribution to journal › Article
- 2014
-
Mark
Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.
(
- Contribution to journal › Article
- 2013
-
Mark
Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009
(
- Contribution to journal › Article
- 2007
-
Mark
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation - Experience from the SPORTIF III and V trials
(
- Contribution to journal › Article
- 2003
-
Mark
Ximelagatran Compared with Warfarain for prevention of thromboembolism in patients with nonvalvular atiral fibrillaton: Rationale. Objectives and design of a pair of clinical trials and baseline patient characteristics (SPORTIF III and V).
(
- Contribution to journal › Article